期刊文献+

精神分裂症患者服药依从性的评价方法(综述) 被引量:103

Assessment of compliance with antipsychotic treatment in schizophrenic patients: A review
下载PDF
导出
摘要 服药依从性是影响精神分裂症患者治疗效果的重要因素之一。本文通过对国内外现有资料进行检索复习,总结了精神分裂症患者服药依从性的主要评价方法,可分为主观评价方法和客观评价方法两大类。主观评价方法从态度(药物态度量表、服药影响因素评定量表、药物依从性评定量表)和行为(Morisky量表、日常服药量表、简明依从性评定量表)两方面进行评价,客观评价方法包括服药记录、药片计数、处方药记录、电子监测、生物检测等,尽管对服药依从性实质是"患者的服药行为与医嘱的一致性"已有广泛认同,可操作性的评价方法也不断发展,但这些方法都有其局限性,根据实际情况同时采用主观与客观评价方法进行调查可以提高结果的准确性。发展效度、信度令人满意而又简单易操作的评价方法作为"金标准"是今后方法学发展上的突破点。 Medication compliance is one of the most important factors of treatment effect of patients with schizophrenia. This article summarized a variety of methods to measure medication compliance through literature review in order to provide evidence for choosing suitable method. Measures of medication adherence fall into two basic categories: subjective methods and objective methods. Subjective methods include attitude scales ( Drug Attitude Inventory, Rating of Medication Influences, and Medication Adherence Rating Scale) and behavior scales (Morisky Medication Adherence Questionnaire, Tablets Routine Questionnaire, Brief Adherence Rating Scale) . Objective methods include medication records, pill counts, prescription records, technology-assisted monitoring, and biologic measures. Although the definition of medication compliance has been widely agreed and the evaluation methods are developing, different methods have different limitations and a "gold standard" needs to be explored. Adopting both objective and subjective method can enhance the accuracy of results. Achieving a "gold standard" which is objective, effective, simple and convenient would be a big breakthrough in methodology.
出处 《中国心理卫生杂志》 CSSCI CSCD 北大核心 2014年第1期45-50,共6页 Chinese Mental Health Journal
关键词 精神分裂症 依从性 综述 schizophrenia compliance reviews
  • 相关文献

参考文献85

  • 1Kinross-Wright V. Chlorpromazine;a major advance in psychiatric treatment[J].{H}Postgraduate Medicine,1954,(4):297-299.
  • 2Bower WH. Chlorpromazine in psychiatric illness[J].{H}New England Journal of Medicine,1954,(17):689-692.
  • 3Gilmer TP,Dolder CR,Lacro JP. Adherence to treatment with antipsychotic medication and health care costs among Medicaid beneficiaries with schizophrenia[J].{H}American Journal of Psychiatry,2004,(4):692-699.
  • 4Velligan DI,Lam YW,Glahn DC. Defining and assessing adherence to oral antipchotics:a review of the literature[J].{H}Schizophrenia Bulletin,2006,(4):724-742.
  • 5Oehl M,Hummer M,Fleischhaeker WW. Compliance with antipsychotic treatment[J].{H}Acta Psychiatrica Scandinavica,2000,(Suppl 407):83-86.
  • 6Seltzer A,Roncari I,Garfinkel P. Effect of patient education on medication compliance[J].{H}Canada Journal of Psychiatry,1980,(8):638-645.
  • 7Olarte SW,Masnik R. Enhancing medication compliance in coffee groups[J].{H}Hospital and Community Psychiarty,1981,(6):417-419.
  • 8Zygmunt A,Olfson M,Boyer CA. Interventions to improve medication adherence in schizophrenia[J].{H}American Journal of Psychiatry,2002,(10):1653-1664.
  • 9Gaebel W. Towards the improvement of compliance:the significance of psycho-education and new antipsychotic drugs[J].{H}International Clinical Psychopharmacology,1997,(Suppl 1):S37-S42.
  • 10Lacro JP,Dunn LB,Dolder CR. Prevalence of and risk factors for medication nonadherence in patients with schizophrenia:a comprehensive review of recent literature[J].{H}Journal of Clinical Psychiatry,2002,(10):892-909.

二级参考文献37

共引文献268

同被引文献891

引证文献103

二级引证文献915

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部